English
Home > Products > Fondaparinux sodium API

China Fondaparinux sodium API Factory

We hold strengthening and perfecting our items and repair. At the same time, we get the job done actively to do research and progress for Fondaparinux sodium API,CAS NO 114870-03-0,114870-03-0, We welcome new and aged buyers from all walks of lifetime to make contact with us for potential small business associations and mutual success!
Fondaparinux sodium API, We've got 48 provincial agencies in the country. We also have stable cooperation with several international trading companies. They place order with us and export solutions to other countries. We expect to cooperate with you to develop a larger market.

Related Products

Hot Products

  • N-(5-Chloropyridin-2-yl)oxalaMic acid ethyl ester

    N-(5-Chloropyridin-2-yl)oxalaMic acid ethyl ester

    Product Name:N-(5-Chloropyridin-2-yl)oxalaMic acid ethyl ester
    Molecular Formula:C9H9ClN2O3
    Molecular Weight:228.63
    CAS Registry Number:349125-08-2
  • Lasmiditan succinate

    Lasmiditan succinate

    Product Name:Lasmiditan succinate
    Molecular Formula:C23H24F3N3O6
    Molecular Weight;495.46
    CAS Registry Number;439239-92-6
  • 3-benzyl-6-bromo-2-methoxyquinoline

    3-benzyl-6-bromo-2-methoxyquinoline

    Product Name:3-benzyl-6-bromo-2-methoxyquinoline
    Molecular Formula:C17H14BrNO
    Molecular Weight:328.2
    CAS Registry Number:654655-69-3
  • Ropivacaine mesylate

    Ropivacaine mesylate

    Product Name:Ropivacaine mesylate
    Molecular Formula:C18H30N2O4S
    Molecular Weight;370.51
    CAS Registry Number;854056-07-8
  • lumateperone (Tosylate)

    lumateperone (Tosylate)

    Product Name:lumateperone (Tosylate)
    Molecular Formula:C31H36FN3O4S
    Molecular Weight;565.7
    CAS Registry Number;1187020-80-9
  • 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate

    3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate

    Product Name:3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate
    Molecular Formula:C11H10N2O4
    Molecular Weight:234.21
    CAS Registry Number:179688-53-0
  • Related Blog
  • Reviews

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept